AAAAAA

   
Results: 1-25 | 26-50 | 51-61
Results: 1-25/61
TESTING FOR HIV-1, HBV AND HCV GENOMES US ING NUCLEIC-ACID AMPLIFICATION TECHNIQUES FOR RED-BLOOD-CELL CONCENTRATES - REPLY
Authors: BEIN G GURTLER L
Citation: G. Bein et L. Gurtler, TESTING FOR HIV-1, HBV AND HCV GENOMES US ING NUCLEIC-ACID AMPLIFICATION TECHNIQUES FOR RED-BLOOD-CELL CONCENTRATES - REPLY, Infusionstherapie und Transfusionsmedizin, 25(2-3), 1998, pp. 180-181
THE IMPACT OF HIV SUBTYPES AND VARIANTS ON THE STABILITY OF HIV SCREENING ASSAYS
Authors: GURTLER L
Citation: L. Gurtler, THE IMPACT OF HIV SUBTYPES AND VARIANTS ON THE STABILITY OF HIV SCREENING ASSAYS, Infusionstherapie und Transfusionsmedizin, 25(2-3), 1998, pp. 198-199
CREUTZFELDT-JAKOB-DISEASE AND HUMAN TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
Authors: BURGER R GERLICH W GURTLER L HEIDEN M KRETSCHNER V LEFEVRE H LOWER J MONTAGLESSING T NEUMANN R PAULI G SEITZ R SCHLENKRICH U WERNER E WILLKOMMEN H
Citation: R. Burger et al., CREUTZFELDT-JAKOB-DISEASE AND HUMAN TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES, Infusionstherapie und Transfusionsmedizin, 25, 1998, pp. 89-96
PARVOVIRUS B19
Authors: BURGER R GERLICH W GURTLER L HEIDEN M KRETSCHNER V LEFEVRE H LOWER J MONTAGLESSING T NEUMANN R PAULI G SEITZ R SCHLENKRICH U WERNER E WILLKOMEN H
Citation: R. Burger et al., PARVOVIRUS B19, Infusionstherapie und Transfusionsmedizin, 25, 1998, pp. 97-102
GB VIRUS TYPE-C (GBV-C), ALTERNATIVE DENOMINATION HEPATITIS-G VIRUS (HGV)
Authors: BURGER R GERLICH W GURTLER L HEIDEN M KRETCHMER V LEFEVRE H LOWER J MONTAGLESSING T NEUMANN R PAULI G SEITZ R SCHLENKRICH U WERNER E WILLKOMMEN H SCHREIER E NUBLING M
Citation: R. Burger et al., GB VIRUS TYPE-C (GBV-C), ALTERNATIVE DENOMINATION HEPATITIS-G VIRUS (HGV), Infusionstherapie und Transfusionsmedizin, 25, 1998, pp. 103-106
COMPARISON OF 2 ANTIRETROVIRAL TRIPLE COMBINATIONS INCLUDING THE PROTEASE INHIBITOR INDINAVIR IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: WINTERGERST U HOFFMANN F SOLDER B NOTHEIS G PETROPOULOU T EBERLE J GURTLER L BELOHRADSKY BH
Citation: U. Wintergerst et al., COMPARISON OF 2 ANTIRETROVIRAL TRIPLE COMBINATIONS INCLUDING THE PROTEASE INHIBITOR INDINAVIR IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Pediatric infectious disease journal, 17(6), 1998, pp. 495-499
HIV TYPE-1 V3 SEROTYPING OF TANZANIAN SAMPLES - PROBABLE REASONS FOR MISMATCHING WITH GENETIC SUBTYPING
Authors: HOELSCHER M HANKER S BARIN F CHEINGSONGPOPOV R DIETRICH U JORDANHARDER B OLALEYE D NAGELE E MARKUZZI A MWAKAGILE D MINJA F WEBER J GURTLER L VONSONNENBURG F
Citation: M. Hoelscher et al., HIV TYPE-1 V3 SEROTYPING OF TANZANIAN SAMPLES - PROBABLE REASONS FOR MISMATCHING WITH GENETIC SUBTYPING, AIDS research and human retroviruses, 14(2), 1998, pp. 139-149
EVALUATION OF DIFFERENT V3 PEPTIDES IN AN ENZYME-IMMUNOASSAY FOR SPECIFIC HIV TYPE-1 GROUP-O ANTIBODY DETECTION
Authors: ONDOA P WILLEMS B FRANSEN K NKENGASONG J JANSSENS W HEYNDRICKX L ZEKENG L NDUMBE P SIMON F SARAGOSTI S GURTLER L PEETERS M KORBER B GOUDSMIT J VANDERGROEN G
Citation: P. Ondoa et al., EVALUATION OF DIFFERENT V3 PEPTIDES IN AN ENZYME-IMMUNOASSAY FOR SPECIFIC HIV TYPE-1 GROUP-O ANTIBODY DETECTION, AIDS research and human retroviruses, 14(11), 1998, pp. 963-972
DIFFERENTIAL-DIAGNOSIS OF HIV TYPE-1 GROUP-O AND GROUP-M INFECTION BYPOLYMERASE-CHAIN-REACTION AND PSTI RESTRICTION ANALYSIS OF THE POL GENE FRAGMENT
Authors: HEYNDRICKX L JANSSENS W GURTLER L ZEKENG L LOUSSERTAJAKA I VEREECKEN K WILLEMS B COPPENS S NDUMBE P FRANSEN K SAMAN E ALARY M VANDERGROEN G
Citation: L. Heyndrickx et al., DIFFERENTIAL-DIAGNOSIS OF HIV TYPE-1 GROUP-O AND GROUP-M INFECTION BYPOLYMERASE-CHAIN-REACTION AND PSTI RESTRICTION ANALYSIS OF THE POL GENE FRAGMENT, AIDS research and human retroviruses, 14(11), 1998, pp. 973-977
REDUCTION OF THE DIAGNOSTIC WINDOW WITH A NEW COMBINED P24 ANTIGEN AND HUMAN-IMMUNODEFICIENCY-VIRUS ANTIBODY SCREENING ASSAY
Authors: GURTLER L MUHLBACHER A MICHL U HOFMANN H PAGGI GG BOSSI V THORSTENSSON R VILLAESCUSA RG EIRAS A HERNANDEZ JM MELCHIOR W DONIE F WEBER B
Citation: L. Gurtler et al., REDUCTION OF THE DIAGNOSTIC WINDOW WITH A NEW COMBINED P24 ANTIGEN AND HUMAN-IMMUNODEFICIENCY-VIRUS ANTIBODY SCREENING ASSAY, Journal of virological methods, 75(1), 1998, pp. 27-38
HIV-1 INFECTION BY ARTIFICIAL-INSEMINATION
Authors: MATZ B KUPFER B KO Y WALGER P VETTER H EBERLE J GURTLER L
Citation: B. Matz et al., HIV-1 INFECTION BY ARTIFICIAL-INSEMINATION, Lancet, 351(9104), 1998, pp. 728-728
COMPLEMENT ACTIVATION BY H1V-1-INFECTED CELLS - THE ROLE OF TRANSMEMBRANE GLYCOPROTEIN GP41
Authors: MARSCHANG P KRUGER U OCHSENBAUER C GURTLER L HITTMAIR A BOSCH V PATSCH JR DIERICH MP
Citation: P. Marschang et al., COMPLEMENT ACTIVATION BY H1V-1-INFECTED CELLS - THE ROLE OF TRANSMEMBRANE GLYCOPROTEIN GP41, Journal of acquired immune deficiency syndromes and human retrovirology, 14(2), 1997, pp. 102-109
SCREENING OF RED-CELL CONCENTRATES ON HIV -1, HBV AND HCV BY GENE AMPLIFICATION TECHNIQUE
Authors: KRETSCHMER V SIBROWSKI W BEIN G GURTLER L
Citation: V. Kretschmer et al., SCREENING OF RED-CELL CONCENTRATES ON HIV -1, HBV AND HCV BY GENE AMPLIFICATION TECHNIQUE, Infusionstherapie und Transfusionsmedizin, 24(3), 1997, pp. 125-129
GENETIC-ANALYSIS OF HIV TYPE-1 GROUP-O P24(GAG) SEQUENCES FROM CAMEROON AND EQUATORIAL-GUINEA
Authors: HACKETT J ZEKENG L BRENNAN CA LUND JK VALLARI AS HICKMAN RK GURTLER L KAPTUE L DEVARE SG
Citation: J. Hackett et al., GENETIC-ANALYSIS OF HIV TYPE-1 GROUP-O P24(GAG) SEQUENCES FROM CAMEROON AND EQUATORIAL-GUINEA, AIDS research and human retroviruses, 13(13), 1997, pp. 1155-1158
SEQUENCE OF GP41(ENV) IMMUNODOMINANT REGION OF HIV TYPE-1 GROUP-O FROM WEST CENTRAL-AFRICA
Authors: BRENNAN CA HACKETT J ZEKENG L LUND JK VALLARI AS HICKMAN RK GURTLER L KAPTUE L VONOVERBECK J HAMPL H DEVARE SG
Citation: Ca. Brennan et al., SEQUENCE OF GP41(ENV) IMMUNODOMINANT REGION OF HIV TYPE-1 GROUP-O FROM WEST CENTRAL-AFRICA, AIDS research and human retroviruses, 13(10), 1997, pp. 901-904
RECENT ASPECTS OF HIV AND HIV-RELATED DISEASES
Authors: GURTLER L
Citation: L. Gurtler, RECENT ASPECTS OF HIV AND HIV-RELATED DISEASES, Infection, 25(2), 1997, pp. 71-73
INHIBITION OF TRYPTASE TL2 FROM HUMAN T4(-1 REPLICATION IN H9 CELLS BY RECOMBINANT APROTININ AND BIKUNIN HOMOLOGS() LYMPHOCYTES AND INHIBITION OF HIV)
Authors: BRINKMANN T SCHAFERS J GURTLER L KIDO H NIWA Y KATUNUMA N TSCHESCHE H
Citation: T. Brinkmann et al., INHIBITION OF TRYPTASE TL2 FROM HUMAN T4(-1 REPLICATION IN H9 CELLS BY RECOMBINANT APROTININ AND BIKUNIN HOMOLOGS() LYMPHOCYTES AND INHIBITION OF HIV), Journal of protein chemistry, 16(6), 1997, pp. 651-660
HIV-1 SUBTYPES - IMPLICATIONS FOR EPIDEMIOLOGY, PATHOGENICITY, VACCINES AND DIAGNOSTICS - WORKSHOP REPORT FROM THE EUROPEAN-COMMISSION (DG-XII, INCO-DC) AND THE JOINT UNITED-NATIONS PROGRAM ON HIV AIDS/
Authors: ASJO B BARIN F BIBERFELD G BRADAC J BUVE A DIELLY S FONTANET A GURTLER L VANDERGROEN G HOELSCHER M HOLMHANSEN C HU D JORDANHARDER B KALEEBU P KAPTUE L KORBER B LEVIN A LUKASHOV V LYAMUYA E MBOUP S MCCUTCHAN FE JACKSON HM MHALU F MKWERA H MSOBI N MULLINS J MWAKAGILE D NANDI J NKENGASONG J NUKULILA T OSMANOV S PEETERS M PLETSCHETTE M SCARLATTI G SHAO J SHAO YM SONNENBURG FV SUTHERLAND D TENNAGASHAW M URASSA W DEVINCENZI I WEBER J WILLIAMSON C WOLF H
Citation: B. Asjo et al., HIV-1 SUBTYPES - IMPLICATIONS FOR EPIDEMIOLOGY, PATHOGENICITY, VACCINES AND DIAGNOSTICS - WORKSHOP REPORT FROM THE EUROPEAN-COMMISSION (DG-XII, INCO-DC) AND THE JOINT UNITED-NATIONS PROGRAM ON HIV AIDS/, AIDS, 11(15), 1997, pp. 17-36
UPDATE ON HIV-1 GROUP-O INFECTION IN EQUATORIAL-GUINEA, CENTRAL-AFRICA
Authors: ZEKENG L SIMA JO HAMPL H NDEMESOGO JM NTUTUMU J SIMA V DEVARE S KAPTUE L GURTLER L
Citation: L. Zekeng et al., UPDATE ON HIV-1 GROUP-O INFECTION IN EQUATORIAL-GUINEA, CENTRAL-AFRICA, AIDS, 11(11), 1997, pp. 1410-1412
EVALUATION OF THE INACTIVATION OF HIV-1 I N HUMAN FEMORAL HEADS BY HEAT-TREATMENT TO 80 DEGREES-C (LOBATOR SD-1)
Authors: VONGARREL T KNAEPLER H GURTLER L
Citation: T. Vongarrel et al., EVALUATION OF THE INACTIVATION OF HIV-1 I N HUMAN FEMORAL HEADS BY HEAT-TREATMENT TO 80 DEGREES-C (LOBATOR SD-1), Der Unfallchirurg, 100(5), 1997, pp. 375-381
EVALUATION OF A QUANTITATIVE DOUBLE ELISA STRATEGY FOR CONFIRMATION AND DIFFERENTIATION OF HIV-INFECTION
Authors: REHLE TM MATTKE P LIOMBA GN KRAMER S GERSHYDAMET GM KONAN K SANGARE A ZEKENG L TSAGUE JM KAPTUE L EBERLE J GURTLER L
Citation: Tm. Rehle et al., EVALUATION OF A QUANTITATIVE DOUBLE ELISA STRATEGY FOR CONFIRMATION AND DIFFERENTIATION OF HIV-INFECTION, Journal of virological methods, 66(2), 1997, pp. 203-209
DETECTION OF GENETICALLY DIVERSE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GROUP-M AND GROUP-O ISOLATES BY PCR
Authors: RESPESS RA BUTCHER A WANG H CHAOWANACHAN T YOUNG N SHAFFER N MASTRO TD BIRYAHWAHO B DOWNING R TANURI A SCHECHTER M PASCU R ZEKENG L KAPTUE L GURTLER L EBERLE J ELLENBERGER D FRIDLUND C RAYFIELD M KWOK S
Citation: Ra. Respess et al., DETECTION OF GENETICALLY DIVERSE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GROUP-M AND GROUP-O ISOLATES BY PCR, Journal of clinical microbiology, 35(5), 1997, pp. 1284-1286
EFFECT OF ANTIRETROVIRAL COMBINATION THERAPY (ZIDOVUDINE DIDANOSINE OR ZIDOVUDINE/LAMIVUDINE) ON QUANTITATIVE PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS RIBONUCLEIC-ACID IN CHILDREN AND ADOLESCENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/
Authors: SOLDER B WINTERGERST U NOTHEIS G EBERLE J GURTLER L BELOHRADSKY BH
Citation: B. Solder et al., EFFECT OF ANTIRETROVIRAL COMBINATION THERAPY (ZIDOVUDINE DIDANOSINE OR ZIDOVUDINE/LAMIVUDINE) ON QUANTITATIVE PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS RIBONUCLEIC-ACID IN CHILDREN AND ADOLESCENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, The Journal of pediatrics, 130(2), 1997, pp. 293-299
STANDARD IMMUNOGLOBULINS - STATUS-REPORT
Authors: ARDJAH H BAENKLER HW FROSNER G GURTLER L JILG W PLASSMANN E RING J VONSONNENBURG F TYMPNER KD
Citation: H. Ardjah et al., STANDARD IMMUNOGLOBULINS - STATUS-REPORT, Der Internist, 38(5), 1997, pp. 494-496
SIGNIFICANCE OF THE INTRODUCTION OF PCR I N BLOOD-BANKS - REPLY
Authors: GURTLER L
Citation: L. Gurtler, SIGNIFICANCE OF THE INTRODUCTION OF PCR I N BLOOD-BANKS - REPLY, Infusionstherapie und Transfusionsmedizin, 23(4-5), 1996, pp. 230-231
Risultati: 1-25 | 26-50 | 51-61